Though ELISA tests (enzyme-linked immunosorbent assays) are the gold standard for diagnosing a whole slew of infectious diseases, the technology has remained stuck within hospital labs. What if you ...

The launch follows increasing demand from the scientific community to study penKid - a biomarker reflecting the current state of kidney function in critical care environments. While SphingoTec's ...

Scientists say they have developed a new computational method to reduce variability in common research biomarker tests. They see their techniques as a promising step in improving the ability of ...

COVID-19 has thrown ELISA testing into the spotlight and driven advances in technology allowing the process to become quicker and more accurate. While there are limits to ELISA antibody tests’ ...

Immunoglobulin (Ig)G and IgE appeared in only 10% of samples tested for possible allergic bronchopulmonary aspergillosis, based on data from more than 500 individuals presented at the American Academy ...

Testing for those who have developed antibodies against the coronavirus can help tackle the ongoing COVID-19 pandemic. Now, a new study has identified all the antibody tests available for the ...

NEW YORK, Oct. 3, 2024 /PRNewswire/ -- Report on how AI is driving market transformation- The global enzyme-linked immunosorbent assay (elisa) market size is estimated to grow by USD 843.9 million ...